(S,R,S)-AHPC-C6-NH2 dihydrochloride is a high-purity E3 Ligase Ligand-Linker Conjugate designed for use in the development of PROTACs (Proteolysis Targeting Chimeras). As part of the PROTAC mechanism, this compound serves as a bifunctional molecule, featuring an AHPC derivative as a ligand for the Von Hippel-Lindau (VHL) E3 ubiquitin ligase, connected via a hexyl (C6) linker terminating in a free amine group for conjugation. This configuration enables the effective recruitment of VHL E3 ligase, facilitating targeted protein ubiquitination and subsequent degradation. (S,R,S)-AHPC-C6-NH2 dihydrochloride is ideal for researchers developing novel protein degraders, exploring new therapeutic targets, or optimizing linker chemistry in drug discovery. Its application extends to evaluating the degradation of disease-related proteins in oncology, immunology, and neurodegenerative research arenas. Leverage this product's optimized design and ready-to-use format to accelerate your PROTAC project today.
Structure of 2341796-77-6
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(S,R,S)-AHPC-C6-NH2 dihydrochloride is a specialized E3 ligase ligand-linker conjugate widely utilized in the development of PROTACs (Proteolysis Targeting Chimeras). As a derivative of the well-characterized AHPC (aryl hydroxyproline carboxamide), it is engineered to recruit the von Hippel-Lindau (VHL) E3 ligase, a key player in ubiquitin-mediated protein degradation. The compound features a flexible hexyl (C6) linker terminated with an amino (NH2) group, optimized for efficient conjugation to target-binding ligands.
Mechanism
(S,R,S)-AHPC-C6-NH2 dihydrochloride functions as a bifunctional building block in PROTAC design. The AHPC moiety selectively binds to the VHL E3 ubiquitin ligase complex, while the C6-NH2 linker enables straightforward attachment to small molecule ligands or peptides specific for the protein of interest. Upon cellular delivery, PROTAC molecules incorporating this conjugate simultaneously engage the target protein and VHL ligase, facilitating the formation of a ternary complex. This proximity triggers ubiquitination and subsequent proteasomal degradation of the target protein, allowing for precise and catalytic removal of disease-associated proteins.
Applications
This VHL ligand-linker conjugate is essential for researchers in drug discovery and chemical biology aiming to create novel PROTACs. Its primary applications include the synthesis of customized PROTAC molecules targeting various disease-associated proteins, especially oncogenic and pathogenic proteins resistant to traditional small molecule inhibitors. (S,R,S)-AHPC-C6-NH2 dihydrochloride is widely used for target validation studies, mechanistic research in targeted protein degradation, and development of next-generation therapeutics in oncology, neurodegeneration, and immunology, offering powerful tools for modulating previously undruggable proteins.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.